Depressão em pacientes com diabetes mellitus: contexto, diagnóstico e tratamento
Resumo
Texto completo:
PDFReferências
Hermelinda Cordeiro Pedrosa. DIRETRIZES SOCIEDADE BRASILEIRA DE DIABETES.; 2020.
Briganti CP, Silva MT, Almeida JV de, Bergamaschi C de C. Association between diabetes mellitus and depressive symptoms in the Brazilian population. Rev Saude Publica. 2019;53(1):1-10. doi:10.11606/S1518-8787.2019053000608
Malta DC, Duncan BB, Schmidt MI, et al. Prevalence of diabetes mellitus as determined by glycated hemoglobin in the Brazilian adult population, national health survey. Rev Bras Epidemiol. 2019;22(Ted 66). doi:10.1590/1980-549720190006.supl.2
Kuniss N, Rechtacek T, Kloos C, et al. Diabetes-related burden and distress in people with diabetes mellitus at primary care level in Germany. Acta Diabetol. 2017;54(5):471-478. doi:10.1007/s00592-017-0972-3
Rewers A. Acute Metabolic Complications in Diabetes. In: Diabetes in America. Vol 3. ; 2016:1-17.
Moulton CD, Pickup JC, Ismail K. The link between depression and diabetes: The search for shared mechanisms. Lancet Diabetes Endocrinol. 2015;3(6):461-471. doi:10.1016/S2213-8587(15)00134-5
Kongkaew C, Jampachaisri K, Chaturongkul CA, Scholfield CN. Depression and adherence to treatment in diabetic children and adolescents: A systematic review and meta-analysis of observational studies. Eur J Pediatr. 2014;173(2):203-212. doi:10.1007/s00431-013-2128-y
Tryggestad JB, Willi SM. Complications and comorbidities of T2DM in adolescents: findings from the TODAY clinical trial. J Diabetes Complications. 2015;29(2):307-312. doi:10.1016/j.jdiacomp.2014.10.009
Education TJ of clinical and applied research and. AMERICAN DIABETES ASSOCIATION. 42nd ed.; 2019. doi:www.diabetes.org/diabetescare
Mancini GBJ, Hegele RA, Leiter LA. Dyslipidemia Diabetes Canada Clinical Practice Guidelines Expert Committee. Can J Diabetes. 2018;42:178-185.
Hofmann M, Köhler B, Leichsenring F, Kruse J. Depression as a risk factor for mortality in individuals with diabetes: A meta-analysis of prospective studies. PLoS One. 2013;8(11):1-7. doi:10.1371/journal.pone.0079809
government of bermuda. Guidelines for Diabetes Care in Bermuda.; 2009.
The Royal Australian College of General Practitioners and Diabetes Australia. Management of Type 2 Diabetes : A Handbook for General Practice.; 2020. https://www.racgp.org.au/getattachment/41fee8dc-7f97-4f87-9d90-b7af337af778/Management-of-type-2-diabetes-A-handbook-for-general-practice.aspx
Abrahamian H, Kautzky-Willer A, Rießland-Seifert A, et al. Mental disorders and diabetes mellitus (Update 2019). Wien Klin Wochenschr. 2019;131(Update):186-195. doi:10.1007/s00508-019-1458-9
Alves E dos S, Francisco AL. Ação psicológica em saúde mental: uma abordagem psicossocial. Psicol Ciência e Profissão. 2009;29(4):768-779. doi:10.1590/s1414-98932009000400009
Young-Hyman D, De Groot M, Hill-Briggs F, Gonzalez JS, Hood K, Peyrot M. Psychosocial care for people with diabetes: A position statement of the American diabetes association. Diabetes Care. 2016;39(12):2126-2140. doi:10.2337/dc16-2053
García-Batista ZE, Guerra-Peña K, Cano-Vindel A, Herrera-Martínez SX, Medrano LA. Validity and reliability of the beck depression inventory (BDI-II) in general and hospital population of Dominican Republic. PLoS One. 2018;13(6):1-12. doi:10.1371/journal.pone.0199750
Rapid T, Service R, Cadth W. Diagnosing, Screening, and Monitoring Depression in the Elderly: A Review of Guidelines. Can Agency Drugs Technol Heal. 2015;(September).
Reese C, Petrak F, Mittag O. Entwicklung von Praxisempfehlungen für psychologische Interventionen in der Rehabilitation von Patienten mit Typ-2-Diabetes: Methoden und Ergebnisse 1. Rehabil. 2016;55(5):299-304. doi:10.1055/s-0042-113936
Baumeister H, Hutter N, Bengel J. Psychological and pharmacological interventions for depression in patients with diabetes mellitus: An abridged Cochrane review. Diabet Med. 2014;31(7):773-786. doi:10.1111/dme.12452
Li C, Xu D, Hu M, et al. A systematic review and meta-analysis of randomized controlled trials of cognitive behavior therapy for patients with diabetes and depression. J Psychosom Res. 2017;95:44-54. doi:10.1016/j.jpsychores.2017.02.006
Uchendu C, Blake H. Effectiveness of cognitive–behavioural therapy on glycaemic control and psychological outcomes in adults with diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. Diabet Med. 2017;34(3):328-339. doi:10.1111/dme.13195
Winkley K, Upsher R, Stahl D, et al. Systematic review and meta-analysis of randomized controlled trials of psychological interventions to improve glycaemic control in children and adults with type 1 diabetes. Diabet Med. 2020;37(5):735-746. doi:10.1111/dme.14264
Winkley K, Landau S, Eisler I, Ismail K. Psychological interventions to improve glycaemic control in patients with type 1 diabetes: Systematic review and meta-analysis of randomised controlled trials. Br Med J. 2006;333(7558):65-68. doi:10.1136/bmj.38874.652569.55
Xie J, Deng W. Psychosocial intervention for patients with type 2 diabetes mellitus and comorbid depression: A meta-analysis of randomized controlled trials. Neuropsychiatr Dis Treat. 2017;13:2681-2690. doi:10.2147/NDT.S116465
Doherty AM, Herrmann-Werner A, Rowe A, Brown J, Weich S, Ismail K. Feasibility study of real-time online text-based CBT to support self-management for people with type 1 diabetes: The Diabetes On-line Therapy (DOT) Study. BMJ Open Diabetes Res Care. 2021;9(1):1-7. doi:10.1136/bmjdrc-2020-001934
Huang Y, Wei X, Wu T, Chen R, Guo A. Collaborative care for patients with depression and diabetes mellitus: a systematic review and meta-analysis. BMC Psychiatry. 2013;13(1):260. doi:10.1186/1471-244X-13-260
Perrin N, Bodicoat DH, Davies MJ, Robertson N, Snoek FJ, Khunti K. Effectiveness of psychoeducational interventions for the treatment of diabetes-specific emotional distress and glycaemic control in people with type 2 diabetes: A systematic review and meta-analysis. Prim Care Diabetes. 2019;13(6):556-567. doi:10.1016/j.pcd.2019.04.001
Jesse CD, Creedy DK, Anderson DJ. Effectiveness of psychological interventions for women with type 2 diabetes who are overweight or obese: A systematic review protocol. JBI Database Syst Rev Implement Reports. 2019;17(3):281-289. doi:10.11124/JBISRIR-2017-003589
Barnard K, Peveler RC, Holt RIG. Antidepressant medication as a risk factor for type 2 diabetes and impaired glucose regulation. Diabetes Care. 2013;36(10):3337-3345. doi:10.2337/dc13-0560
Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018;391(10128):1357-1366. doi:10.1016/S0140-6736(17)32802-7
Dodd S, Mitchell PB, Bauer M, et al. Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statement. World J Biol Psychiatry. 2018;19(5):330-348. doi:10.1080/15622975.2017.1379609
Correll CU, Detraux J, De Lepeleire J, De Hert M. Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder. World Psychiatry. 2015;14(2):119-136. doi:10.1002/wps.20204
Cezaretto A, Ferreira SRG, Sharma S, Sadeghirad B, Kolahdooz F. Impact of lifestyle interventions on depressive symptoms in individuals at-risk of, or with, type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis. 2016;26(8):649-662. doi:10.1016/j.numecd.2016.04.009
Davis B, Qian J, Ngorsuraches S, Jeminiwa R, Garza KB. The clinical impact of pharmacist services on mental health collaborative teams: A systematic review. J Am Pharm Assoc. 2020;60(5):S44-S53. doi:10.1016/j.japh.2020.05.006
Milosavljevic A, Aspden T, Harrison J. Community pharmacist-led interventions and their impact on patients’ medication adherence and other health outcomes: a systematic review. Int J Pharm Pract. 2018;26(5):387-397. doi:10.1111/ijpp.12462
Cohen LB, Taveira TH, Wu WC, Pirraglia PA. Pharmacist-led telehealth disease management program for patients with diabetes and depression. J Telemed Telecare. 2020;26(5):294-302. doi:10.1177/1357633X18822575
Readdean KC, Heuer AJ, Scott Parrott J. Effect of pharmacist intervention on improving antidepressant medication adherence and depression symptomology: A systematic review and meta-analysis. Res Soc Adm Pharm. 2018;14(4):321-331. doi:10.1016/j.sapharm.2017.05.008
van Eikenhorst L, Taxis K, van Dijk L, de Gier H. Pharmacist-led self-management interventions to improve diabetes outcomes. A systematic literature review and meta-analysis. Front Pharmacol. 2017;8(DEC):1-14. doi:10.3389/fphar.2017.00891
Presley B, Groot W, Pavlova M. Pharmacy-led interventions to improve medication adherence among adults with diabetes: A systematic review and meta-analysis. Res Soc Adm Pharm. 2019;15(9):1057-1067. doi:10.1016/j.sapharm.2018.09.021
Nogueira M, Otuyama LJ, Rocha PA, Pinto VB. Pharmaceutical care-based interventions in type 2 diabetes mellitus : a systematic review and meta-analysis of randomized clinical trials. Einstein (Sao Paulo). 2020;18:eRW4686. doi:10.31744/einstein_journal/2020RW4686
DOI: http://dx.doi.org/10.14450/2763-7654.v25.e3.a2021.pp5-13
Apontamentos
- Não há apontamentos.
Direitos autorais 2022 Cristiane de Cassia Bergamaschi
Este obra está licenciado com uma Licença Creative Commons Atribuição-NãoComercial-SemDerivações 4.0 Internacional.
Boletim Farmacoterapêutica
ISSN - 2763-7654 (Versão eletrônica)
ISSN - 1413-9626 (Versão impressa)
Indexadores:
